4-Aminosalicylic acid (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "4-Aminosalicylic acid" in English language version.

refsWebsite

Global rank English rank

23nih.gov

4^th place

15doi.org

2^nd place

2handle.net

102^nd place

76^th place

2drugs.com

399^th place

333^rd place

2web.archive.org

1^st place

2semanticscholar.org

11^th place

8^th place

1europa.eu

68^th place

117^th place

1rxlist.com

7,927^th place

6,815^th place

1fda.gov

447^th place

338^th place

doi.org

Donald PR, Diacon AH (September 2015). "Para-aminosalicylic acid: the return of an old friend". The Lancet. Infectious Diseases. 15 (9): 1091–1099. doi:10.1016/s1473-3099(15)00263-7. PMID 26277036.
Smith NP, Ryan TJ, Sanderson KV, Sarkany I (March 1976). "Lichen scrofulosorum. A report of four cases". The British Journal of Dermatology. 94 (3): 319–325. doi:10.1111/j.1365-2133.1976.tb04391.x. PMID 1252363. S2CID 26281951.
Black JM, Sutherland IB (June 1961). "Two Incidents of Tuberculous Infection by Milk from Attested Herds". British Medical Journal. 1 (5241): 1732–1735. doi:10.1136/bmj.1.5241.1732. PMC 1954350. PMID 20789163.
Daniel F, Seksik P, Cacheux W, Jian R, Marteau P (May 2004). "Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis". Inflammatory Bowel Diseases. 10 (3): 258–260. doi:10.1097/00054725-200405000-00013. PMID 15290921.
Jiang YM, Mo XA, Du FQ, Fu X, Zhu XY, Gao HY, et al. (June 2006). "Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study". Journal of Occupational and Environmental Medicine. 48 (6): 644–649. doi:10.1097/01.jom.0000204114.01893.3e. PMC 4180660. PMID 16766929.
Das KM, Eastwood MA, McManus JP, Sircus W (September 1973). "Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype". The New England Journal of Medicine. 289 (10): 491–495. doi:10.1056/NEJM197309062891001. PMID 4146729.
Szeinberg A, Sheba C, Hirshorn N, Bodonyi E (July 1957). "Studies on erthrocytes in cases with past history of favism and drug-induced acute hemolytic anemia". Blood. 12 (7): 603–613. doi:10.1182/blood.V12.7.603.603. PMID 13436516.
Macgregor AG, Somner AR (November 1954). "The anti-thyroid action of para-aminosalicylic acid". Lancet. 267 (6845): 931–936. doi:10.1016/S0140-6736(54)92552-0. PMID 13213079.
Boman G (1974). "Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid". European Journal of Clinical Pharmacology. 7 (3): 217–225. doi:10.1007/BF00560384. PMID 4854257. S2CID 24202603.
Vetuschi C, Ragno G, Mazzeo P (1988). "Determination of p-aminosalicylic acid and m-aminophenol by derivative UV-spectrophotometry". Journal of Pharmaceutical and Biomedical Analysis. 6 (4): 383–391. doi:10.1016/0731-7085(88)80003-7. PMID 16867404.
Zheng J, Rubin EJ, Bifani P, Mathys V, Lim V, Au M, et al. (August 2013). "para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis". The Journal of Biological Chemistry. 288 (32): 23447–23456. doi:10.1074/jbc.m113.475798. PMC 3789992. PMID 23779105.
Minato Y, Thiede JM, Kordus SL, McKlveen EJ, Turman BJ, Baughn AD (September 2015). "Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance". Antimicrobial Agents and Chemotherapy. 59 (9): 5097–5106. doi:10.1128/AAC.00647-15. PMC 4538520. PMID 26033719.
Zhao F, Wang XD, Erber LN, Luo M, Guo AZ, Yang SS, et al. (1 January 2014). "Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis". Antimicrobial Agents and Chemotherapy. 58 (3): 1479–1487. doi:10.1128/aac.01775-13. PMC 3957869. PMID 24366731.
Lehmann J (December 1949). "The treatment of tuberculosis in Sweden with para-aminosalicylic acid; a review". Diseases of the Chest. 16 (6): 684–703, illust. doi:10.1378/chest.16.6.684. PMID 15396516.
Lehmann J (January 1946). "Para-aminosalicylic acid in the treatment of tuberculosis". Lancet. 1 (6384): 15–16. doi:10.1016/s0140-6736(46)91185-3. PMID 21008766.

drugs.com

"Aminosalicylic Acid". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
"Aminosalicylic acid (Paser) Use During Pregnancy". Drugs.com. 28 February 2020. Retrieved 3 April 2020.

europa.eu

ema.europa.eu

"Granupas (previously Para-aminosalicylic acid Lucane)". European Medicines Agency (EMA). 17 September 2018. Retrieved 3 April 2020.

fda.gov

accessdata.fda.gov

"Paser: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 3 April 2020.

handle.net

hdl.handle.net

World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 140. hdl:10665/44053. ISBN 9789241547659.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

nih.gov

pubmed.ncbi.nlm.nih.gov

Donald PR, Diacon AH (September 2015). "Para-aminosalicylic acid: the return of an old friend". The Lancet. Infectious Diseases. 15 (9): 1091–1099. doi:10.1016/s1473-3099(15)00263-7. PMID 26277036.
Mitchison DA (September 2000). "Role of individual drugs in the chemotherapy of tuberculosis". The International Journal of Tuberculosis and Lung Disease. 4 (9): 796–806. PMID 10985648.
Fox W, Ellard GA, Mitchison DA (October 1999). "Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications". The International Journal of Tuberculosis and Lung Disease. 3 (10 Suppl 2): S231–S279. PMID 10529902.
Smith NP, Ryan TJ, Sanderson KV, Sarkany I (March 1976). "Lichen scrofulosorum. A report of four cases". The British Journal of Dermatology. 94 (3): 319–325. doi:10.1111/j.1365-2133.1976.tb04391.x. PMID 1252363. S2CID 26281951.
Black JM, Sutherland IB (June 1961). "Two Incidents of Tuberculous Infection by Milk from Attested Herds". British Medical Journal. 1 (5241): 1732–1735. doi:10.1136/bmj.1.5241.1732. PMC 1954350. PMID 20789163.
Daniel F, Seksik P, Cacheux W, Jian R, Marteau P (May 2004). "Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis". Inflammatory Bowel Diseases. 10 (3): 258–260. doi:10.1097/00054725-200405000-00013. PMID 15290921.
Jiang YM, Mo XA, Du FQ, Fu X, Zhu XY, Gao HY, et al. (June 2006). "Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study". Journal of Occupational and Environmental Medicine. 48 (6): 644–649. doi:10.1097/01.jom.0000204114.01893.3e. PMC 4180660. PMID 16766929.
Das KM, Eastwood MA, McManus JP, Sircus W (September 1973). "Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype". The New England Journal of Medicine. 289 (10): 491–495. doi:10.1056/NEJM197309062891001. PMID 4146729.
Szeinberg A, Sheba C, Hirshorn N, Bodonyi E (July 1957). "Studies on erthrocytes in cases with past history of favism and drug-induced acute hemolytic anemia". Blood. 12 (7): 603–613. doi:10.1182/blood.V12.7.603.603. PMID 13436516.
Macgregor AG, Somner AR (November 1954). "The anti-thyroid action of para-aminosalicylic acid". Lancet. 267 (6845): 931–936. doi:10.1016/S0140-6736(54)92552-0. PMID 13213079.
Boman G (1974). "Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid". European Journal of Clinical Pharmacology. 7 (3): 217–225. doi:10.1007/BF00560384. PMID 4854257. S2CID 24202603.
Vetuschi C, Ragno G, Mazzeo P (1988). "Determination of p-aminosalicylic acid and m-aminophenol by derivative UV-spectrophotometry". Journal of Pharmaceutical and Biomedical Analysis. 6 (4): 383–391. doi:10.1016/0731-7085(88)80003-7. PMID 16867404.
Zheng J, Rubin EJ, Bifani P, Mathys V, Lim V, Au M, et al. (August 2013). "para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis". The Journal of Biological Chemistry. 288 (32): 23447–23456. doi:10.1074/jbc.m113.475798. PMC 3789992. PMID 23779105.
Minato Y, Thiede JM, Kordus SL, McKlveen EJ, Turman BJ, Baughn AD (September 2015). "Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance". Antimicrobial Agents and Chemotherapy. 59 (9): 5097–5106. doi:10.1128/AAC.00647-15. PMC 4538520. PMID 26033719.
Zhao F, Wang XD, Erber LN, Luo M, Guo AZ, Yang SS, et al. (1 January 2014). "Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis". Antimicrobial Agents and Chemotherapy. 58 (3): 1479–1487. doi:10.1128/aac.01775-13. PMC 3957869. PMID 24366731.
Lehmann J (December 1949). "The treatment of tuberculosis in Sweden with para-aminosalicylic acid; a review". Diseases of the Chest. 16 (6): 684–703, illust. doi:10.1378/chest.16.6.684. PMID 15396516.
Lehmann J (January 1946). "Para-aminosalicylic acid in the treatment of tuberculosis". Lancet. 1 (6384): 15–16. doi:10.1016/s0140-6736(46)91185-3. PMID 21008766.

ncbi.nlm.nih.gov

Black JM, Sutherland IB (June 1961). "Two Incidents of Tuberculous Infection by Milk from Attested Herds". British Medical Journal. 1 (5241): 1732–1735. doi:10.1136/bmj.1.5241.1732. PMC 1954350. PMID 20789163.
Jiang YM, Mo XA, Du FQ, Fu X, Zhu XY, Gao HY, et al. (June 2006). "Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study". Journal of Occupational and Environmental Medicine. 48 (6): 644–649. doi:10.1097/01.jom.0000204114.01893.3e. PMC 4180660. PMID 16766929.
Zheng J, Rubin EJ, Bifani P, Mathys V, Lim V, Au M, et al. (August 2013). "para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis". The Journal of Biological Chemistry. 288 (32): 23447–23456. doi:10.1074/jbc.m113.475798. PMC 3789992. PMID 23779105.
Minato Y, Thiede JM, Kordus SL, McKlveen EJ, Turman BJ, Baughn AD (September 2015). "Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance". Antimicrobial Agents and Chemotherapy. 59 (9): 5097–5106. doi:10.1128/AAC.00647-15. PMC 4538520. PMID 26033719.
Zhao F, Wang XD, Erber LN, Luo M, Guo AZ, Yang SS, et al. (1 January 2014). "Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis". Antimicrobial Agents and Chemotherapy. 58 (3): 1479–1487. doi:10.1128/aac.01775-13. PMC 3957869. PMID 24366731.

dailymed.nlm.nih.gov

"Paser- aminosalicylic acid granule, delayed release". DailyMed. 1 May 2010. Retrieved 3 April 2020.

rxlist.com

"Paser". RxList. Archived from the original on 13 September 2008. Retrieved 10 October 2008.

semanticscholar.org

api.semanticscholar.org

Smith NP, Ryan TJ, Sanderson KV, Sarkany I (March 1976). "Lichen scrofulosorum. A report of four cases". The British Journal of Dermatology. 94 (3): 319–325. doi:10.1111/j.1365-2133.1976.tb04391.x. PMID 1252363. S2CID 26281951.
Boman G (1974). "Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid". European Journal of Clinical Pharmacology. 7 (3): 217–225. doi:10.1007/BF00560384. PMID 4854257. S2CID 24202603.

web.archive.org

"Aminosalicylic Acid". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
"Paser". RxList. Archived from the original on 13 September 2008. Retrieved 10 October 2008.